Loncom Pharma's Antidiabetic Drugs, featuring Empagliflozin Tablet and Vildagliptin Tablet, are transformative in diabetes management. These medications play a pivotal role in regulating blood sugar levels, enhancing the quality of life for individuals with diabetes, and reducing the risk of complications.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
